Pseudomonas aeruginosa is an opportunistic pathogen and an ubiquitous environmental bacterium. Fifty-seven days after hospitalization, we isolated three distinct P. aeruginosa morphotypes (smooth, rough and mucoid) from the lower respiratory tract of a patient admitted to a Cardiology Intensive Care Unit (ICU). Moreover, a group of nine colony variants, arising from the three P. aeruginosa isolates growing in laboratory growth media, were also isolated. The resulting 12 isolates were characterised for antibiotic resistance profile and subjected to genotypic analysis by fluorescent-Amplified Fragment Length Polymorphism (f-AFLP) and automated repetitive extragenic palindromic-PCR (rep-PCR) fingerprinting. The three smooth, rough and mucoid morphotypes presented different antibiotic resistance profiles and genotyping analysis showed that they belonged to distinct clones, indicating that at day 57 after the admission the patient was simultaneously colonized by three distinct P. aeruginosa isolates. On the other hand, the nine colony variants presented heterogeneous antibiotic resistance profiles and clustered together with the three parental isolates. The understanding of the link between genotype plasticity and antibiotic resistance may contribute to improving our knowledge of this Iifethreatening pathogen.
strains of human and environmental ongm have become available, in silico analysis showed that P. aeruginosa is endowed with high genetic plasticity and that strains able to cause human infections have acquired genomic islands in order to increase their fitness within susceptible hosts (10) (11) (12) (13) (14) (15) (16) (17) .
In cystic fibrosis (CF) patients, a distinguishing microbiological feature of P. aeruginosa, which chronically colonizes the lungs of these patients, is the ability ("hypermutable phenotype") of the persisting clone to segregate different colony variants endowed with different antibiotic resistance and virulence profiles (5) (6) 18) . Moreover, the isolation ofthese variants also in non-CF patients hospitalized in ICUs, is becoming an emerging threat (4, 11) .
In this paper we describe a case of a pulmonary bacterial colonization of a non-CF patient admitted in a cardiology ICU and colonized by three different variants of P. aeruginosa. Namely, at day 57 after the admission, three different P. aeruginosa isolates presenting different colony morphologies (smooth, S; rough, R; and mucoid, M) were isolated from a bronchoalveolar lavage (BAL) fluid. Furthermore, on solid growth medium, each of the three different morphotypes segregated colony variants different from those of parental strains and a total of nine colonies were isolated. To assess genetic relatedness ofthe strains (the three parental and the nine different morphotypes), we evaluated the antibiotic resistance profiles of the twelve isolates together with a genotypic fingerprinting analysis using conventional fluorescent-Amplified Fragment Length Polymorphism (f-AFLP) and repetitive-sequence-based PCR (rep-PCR) methodologies (19) (20) (21) .
MATERIALS AND METHODS
In July 2006, a 73-year-old male was admitted to the Emergency Department of the Sant' Andrea Hospital ("Sapienza" University of Rome, Rome, Italy) with dyspnoea and symptoms related to angina pectoris and was consequently taken to a Cardiology ICU. The patient had a history of type II diabetes mellitus, dilated cardiomyopathy and left ventricular dysfunction. Upon admission, the patient underwent coronariography and doppler echocardiography examinations which revealed the presence of a stenosis of 50% of right coronary. Consequently, the patient underwent angioplastic stent surgery. Bronchoalveolar lavage (BAL) fluids, sputum, urine, wound swabs were cultured to detect growth of aerobic and/or anaerobic microrganisms. Blood samples were evaluated for the presence of bacteria by using the Bactec System (Becton Dickinson). P. aeruginosa identification and antimicrobial susceptibility tests were performed by using Vitek 2.0 system with GN and AST-N022 cards, respectively (BioMerieux). Susceptibility profiles of P. aeruginosa isolates were evaluated by the Advance Expert System of Vitek 2 instrument according to Clinical and Laboratory Standards Institute (CLSI) notes released on 2007.
P. aeruginosa isolates were streaked on tryptic soy agar plates supplemented with 5% sheep blood. Wellisolated colonies were used for direct DNA extraction using the UltraClean Microbial DNA Isolation Kit (MoBio Laboratories), as recommended by the manufacturer. Genotyping of P. aeruginosa isolates was performed by using both f-AFLP Microbial fingerprinting (Applied Biosystems) and DiversiLab Pseudomonas rep-PCR (BioMerieux) kits, following manufacturer instructions. f-AFLP fingerprinting was performed using T4 DNA ligase, EcoRI and MseI restriction enzymes (New England BioLabs), and P. aeruginosa specific primers EcoRI-O (carboxyfluorescein labelled) and MseI-C, as described (21) . f-AFLP profiles were resolved by a AB13130/XL automated fluorescence genetic analyzer (Applied Biosystems). Normalization and fragment sizing were carried out using the GeneScan-500 ROX size standard (Applied Biosystems). f-AFLP profiles were analyzed by using BioNumerics ver 5.00 (Applied Maths) software. Only DNA fragments in the range of 80-450 bp were considered. Similarity was calculated using productmoment Pearson correlation coefficient for banding pattern interpretation. Relationship amongst groups was displayed by a dendrogram based on Unweighted Pair Group Method with Arithmetic mean (UPGMA) elaboration. A threshold of 95% similarity was used to assess clustering.
For what it concerns rep-PCR fingerprinting, separation of amplified fragments and profile analysis were carried out using the DiversiLab technological platform (BioMerieux) which consists of an Agilent 2100 bioanalyzer (Agilent Technologies) and the DiversiLab web-based software (v. 2.1.66). The distance matrix and the clustering analysis were based on Kullback-Leibler correlation coefficient and UPGMA method, respectively. The threshold was fixed at 97% similarity, as described (19) (20) .
RESULTS
At day 57 after the admission, three distinct P. aeruginosa isolates presenting smooth, rough and mucoid morphotypes (S, Rand M, respectively), were isolated from the lower respiratory tract of the 73-year old patient taken to the Cardiology ICU of the "Sant'Andrea" Hospital (Table I) . The S, R and M isolates showed three different susceptibility profiles, particularly the Sand R isolates resulted susceptible to I and 4 antibiotics, respectively, while the M isolate was susceptible to the entire 12 antibiotic panel (Table I) . A retrospective analysis revealed that during the course of hospitalization the lower respiratory tract ofthe patient was colonized by P. aeruginosa during the first days of hospitalization (BAL fluids were positive for P. aeruginosa at day 12 and 42 after internalization; Fig. 1 ). Interestingly, the S isolate, but not the Rand M isolates, showed the same antibiotic resistance profile ofthe P. aeruginosa isolates collected at days 12 and 42 (data not shown), indicating that probably the P. aeruginosa isolate with an S morphotype colonized the patient before day 57. Therefore, a detailed analysis of S, Rand M P. aeruginosa isolates was undertaken. On blood agar plates, the S, Rand M isolates generated colony variants presenting different phenotypic traits (S-, Rand M-like variants; Table I ). Namely, the S isolate generated three different S-like colony variants (S1 to S3); the R isolate one R-like variant (Rl); and the M isolate five M-like variants (Ml to M5) (Table I) .
Regarding the antibiotic resistance profile, the S-, R-and M-like variants presented a certain degree of heterogeneity, if compared to parental isolates. Namely, the S-like variants SI and S3 presented the same antibiotic resistance profile of parental S primary isolate, while S2 was susceptible to amikacin; the Rl variant presented an antibiotic resistance profile identical to the S2 variant and significantly different from that of parental R isolate; the M-like variants M2 and M5 were highly susceptible, as the parental M isolate, while Ml and M4 isolates showed an antibiotic resistance profile similar to S2 and M3 identical to R (Table I) . All the isolates were susceptible to ciprofloxacin. These results likely indicate genetic variability among isolates upon cultivation on blood-agar plates. To assess the genetic relatedness of the twelve P. aeruginosa isolates (S and Sl to S3; Rand Rl; and M and Ml to M5), a fingerprinting analysis was performed using f-AFLP and a new commercial rep-PCR genotyping system (see Materials and Methods for details). The f-AFLP and rep-PCR fingerprinting analysis showed that the S, M and R isolates clustered into three distinct genetic clusters (Table  I and Figs. 2 and 3) , indicating that the patient was simultaneously colonized by three distinct strains of P. aeruginosa. f-AFLP analysis of the Sl to S3, RI and MI to M5 colony variants showed that, independently of their antibiotic resistance profiles, they cluster together with their primary S, Rand M isolates (f-AFLP TYPE 1 to 3) ( Fig. 2 and Table I (Harrington et al., 2007; Ross et al., 2005) . The grey rectangles indicates the three different fingerprinting clusters.
PCR TYPE 2 ) ( Fig. 3 and Table I ).
These results indicate that, although some minor discrepancies between the antibiotic resistance profiles and the f-AFLP and the rep-PCR fingerprinting analysis, the S-, R-and M-like colony variants have most probably originated from parental S, Rand M parental isolates.
DISCUSSION
Although most patients, once colonized with P aeruginosa, tend to harbour a conserved clone during the course of the disease, the lower respiratory tract of chronically infected patients (cystic fibrosis patients, ventilated patients taken to ICUs, etc.) may also harbour distinct strains and/or variants of the original clones, which may present different virulence and/or antibiotic resistance profiles, as well as minor differences when subjected by genome fingerprinting analysis (4, (6) (7) (22) (23) (24) . The insurgence of variants mainly depends on the genetic variability of P aeruginosa and on the different type of environmental pressure (for instance, antibiotic therapy) (4, 22) .
Our report depicts a case of a patient admitted to the Cardiology ICU of the Sant' Andrea Hospital, "Sapienza" University of Rome, Rome, Italy, who, at day 57 after admission, presented the lower respiratory tract simultaneously infected by three P aeruginosa isolates showing smooth, rough or mucoid (S, Rand M. respectively) morphotypes. To evaluate whether the three morphotypes originated from the same strain or were distinct clones, the antibiotic resistance profiles and the genetic relatedness (f-AFLP and rep-PCR fingerprinting analysis) were determined. Moreover, upon culturing on blood-agar plates, the three morphotypes segregated colony variants different from parental S, Rand M isolates. A total of nine colony variants were also isolated. The antibiotic resistance profiles and the genetic relatedness of the nine isolates was also determined and compared to those obtained for parental S, Rand M isolates (Table I and Figs. 2 and 3) .
The results clearly indicate that at day 57 the patient was simultaneously colonized by three distinct clones of P. aeruginosa (Figs. 2 and 3 ) that presented distinct antibiotic resistance profiles (namely, the S clone was highly resistant, the R clone presented an intermediate pattern while the M clone was susceptible to all the antibiotics tested; Table I ).
Regarding the S, Rand M colony variants (S-, R-and M-like colony variants SI to S3, Rl and Ml to M5) obtained by growing the strains on blood agar plates, the results of the fingerprinting analysis indicated that they belong to the same clusters of parental S, Rand M clones. Moreover, the antibiotic resistance profile, the S-, R-and M-like colony variants presented a certain degree of heterogeneity, if compared to parental isolates (Table I) , indicating that although they belong to the same clusters as parental strains, at least in vitro P. aeruginosa may segregate genetic variants endowed with different antibiotic resistance profiles and, likely, different virulence traits. These data confirm and extend previous reports indicating that P. aeruginosa may segregate variants presenting different antimicrobial susceptibility and virulence profiles (6-7). Whether or not these variants may have originated in vivo within the patient lower respiratory tract remains an open question and further studies are certainly needed to clarify this point.
